An Encouraging Approach to Complex ASDs: A Multicenter Study
Rasit Aktas1, Nazmi Narin2, Kaan Yildiz3
1Department of Pediatric Cardiology, Health Sciences University Izmir Tepecik Education And Research Hospital, Izmir, TR 35020, Turkey. rasitaktas1989@outlook.com.
None:
Although percutaneous atrial septal defect closure is widely used, the surgical method may be preferred in cases with conditions that complicate transcatheter closure (large defect, rim deficiency or floppy rim, presence of septal aneurysm, multifenestrated defects, low age, and weight). This retrospective study evaluated data from patients with complex atrial septal defects who underwent transcatheter closure between January 2021 and August 2024. The parameters assessed included age, weight, defect size, rim size, septum characteristics, success rates, and complication rates. Transcatheter atrial septal defect closure was performed in 51 patients with complex defects. Two patients had multifenestrated defects, five had multiple defects, and 15 had an aneurysmal septum. Six patients were under one year old, and 21 had defects > 20 mm. In 25 patients, the stretched balloon size/total septum ratio was > 50%, in 44 patients, the balloon diameter/body surface area ratio was > 15 mm/m², and one had a malalignment defect. Among the patients with rim deficiency, six had isolated aortic, six had isolated inferior vena cava, five had isolated superior vena cava, and one had isolated posterior rim deficiency. Three patients had combined aortic and inferior vena cava deficiencies, and one had combined aortic and superior vena cava deficiency. The study revealed no complications except in two cases of device embolization. The success rate was 96.08% across all procedures. Percutaneous closure can be successfully performed in patients with complex atrial septal defects with low complication rates, similar to other atrial septal defects, with good results in experienced centers.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Bioavailability Study Design: Single Versus Multiple Dose Studies
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....


